Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy - Test2 - elhamkhani - TriplyDB

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

http://www.wikidata.org/entity/Q26798420

about

Gastric biomarkers: a global review Molecular targeted therapy for the treatment of gastric cancer Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization What gastric cancer proteomic studies show about gastric carcinogenesis?Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells.Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers.Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening.Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer.Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation.Gastric cancer management: Kinases as a target therapy.DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.Are Mast Cells MASTers in Cancer?Implementing liquid biopsies into clinical decision making for cancer immunotherapy.Gastric adenocarcinoma.w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway.Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine.Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer.IκB-kinase-ε in the tumor microenvironment is essential for the progression of gastric cancer.Eosinophils: The unsung heroes in cancer?Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.Combination treatment of all-trans retinoic acid (ATRA) and γ-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell line.MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1.[Hereditary gastric and pancreatic cancer].Inhibitory effects of isocryptotanshinone on gastric cancer.Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer.New therapeutic options opened by the molecular classification of gastric cancer.The tumor suppressor role of miR-155-5p in gastric cancer.The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors Inhibition of lysyl oxidase expression by dextran sulfate affects invasion and migration of gastric cancer cells

P2860

Q26741859-7B199C17-7F08-4D3F-A4D3-2D34795E9CEC Q28072433-3CC3B6BE-09E6-477A-AC7A-01D120521DB4 Q33657952-C57191A3-8870-4E68-992A-38C6B06449AD Q33798447-7BF75548-AEA4-4A1E-9DD6-DE5626E26E57 Q36002404-6D886718-FFFE-4E8C-8BCD-FD2C630156EF Q36640092-FAD2B081-5DD8-4469-9C76-A5D7D66C7A2C Q36905878-B1DE6E6B-E098-4FB8-A900-F9C97DDD787D Q37342600-B7E70671-6535-479A-B23F-E7CCCBC8D899 Q37376581-72B87E0D-6F6A-4544-9031-C4D6C8A2FB90 Q37407445-C46BB905-0813-44F7-ABF0-FE93230648E5 Q37580332-0A0C4F93-DA1A-4BB8-B40A-FACBE563DECD Q37645061-6C82C19D-34F2-4F40-A743-8F76906FBE45 Q37706478-84D787B4-D65F-4A82-A4B5-32E802629FB2 Q38749038-B29D4882-9FE3-4466-9256-217A62193374 Q38803566-AE269BE9-21A0-4DFB-A10D-DF585D6ACCA7 Q39038994-BAE5B217-4F1C-4C4B-96A2-C8A61ED5BF2B Q39265436-E3866F92-ED92-4733-8CD3-960632FFE993 Q39304648-E9B96E6C-C2D1-4A9E-A14B-49A05616E865 Q39343374-7D019A96-BE4C-4948-BEA2-1C6000BDDF25 Q40209537-7186B077-3E8B-4F5F-8A3F-495742204B83 Q40592991-1F2FDB8D-B315-4065-BB35-1D06257BF9CF Q42160338-89E1577A-5176-460A-844F-0938085012F8 Q42332601-1F174727-10E3-4178-ACEA-52520F747624 Q42358513-009D4F5C-A9C7-48A5-9FAC-7F791F2ACD74 Q46160734-0615CE32-6125-4885-8DAA-60BC54BB6A8E Q47225787-4B2F8444-5642-42FD-978E-686C4BDA12F0 Q48379063-7C7E079F-E346-487A-B4EF-68445D1FA945 Q50125744-18E96CBE-CAE1-47A8-820F-1C673846E2BB Q52629304-5D23157D-8238-41EC-9042-577BB42A8626 Q53929289-ABB0965E-1A22-451A-B1D9-1A3EFD0DE94B Q55343616-7C4BE698-725F-4723-A3CC-6EB6FA374D5A Q55380924-3A3E0B3C-EEE8-42A6-B37E-51036E52D11A Q55527185-3A53FE7B-7419-4421-98FE-C0EF4688A0F6 Q55691713-2CD01E53-5E7D-43EC-AA49-053CB800470E Q56890968-BED70041-D8DB-468B-BA0A-4BC36E7A95FA Q58764034-0010F24E-7067-440D-A296-CA7B272312B7

P2860

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

http://www.wikidata.org/entity/Q26798420

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@ast

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@en

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@nl

type

label

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@ast

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@en

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@nl

prefLabel

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@ast

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@en

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@nl

P1433

Q26798420-6EA0F929-796E-4EAA-A36A-50FF73B573DC

P1476

Q26798420-7E53605E-C4EC-42AB-B1CC-ADA14413A383

P2093

Q26798420-20764795-BC5E-4E19-AC2F-700DBB9B8AA8

Q26798420-25A6CD7F-95F1-4FFC-ABE2-84F4E30AE5C2

Q26798420-638E51B6-06D9-4B2B-9142-7DFE199D2B72

Q26798420-B8DD35D0-F432-49AE-B6CB-E8D958E8A1B1

P275

Q26798420-097B97E6-721E-4F68-BB98-086728294319

P2860

Q26798420-00BAB1FA-1C9E-41E4-8F0C-06813AFDC494

Q26798420-03AFBE85-EA9F-44C9-AE7F-24C5EB089012

Q26798420-03E588D3-ECBB-4899-B54F-0B1D180B22E8

Q26798420-0594C17E-FDCF-460D-9F1A-32BAEBC51B48

Q26798420-05980E76-4ABA-47B9-A869-F6132569ABF9

Q26798420-05D50D0B-A94C-41C3-89D4-813FD2445061

Q26798420-063D34DC-FDE2-4C65-9433-42C35DD5D9E7

Q26798420-08970112-9E03-46F2-A5AC-5D9726CE51BB

Q26798420-0A2EC159-FC76-492A-90F9-6216A0FC1DAA

Q26798420-0A5ED062-7D31-4990-9859-86114F4C49C1

P304

Q26798420-63E03835-C940-4C68-B645-A31C72C28A32

P31

Q26798420-0A63DBDE-3803-418D-A5DA-6E8CEE0D3D57

Q26798420-B9E0554A-A1E8-42E3-8DA6-BB8505B5A6B4

P3181

Q26798420-E7170702-D080-4BA0-A641-E28522B4B8EE

P356

Q26798420-0FD4277C-0CCC-4CD9-AE1B-944540ABC7A3

P407

Q26798420-BCD27796-81DB-4433-80FF-0ECEBC75D675

P433

Q26798420-798CDF89-65FB-47A5-B4F6-74E98807261D

P478

Q26798420-A6111FAF-ECE1-4C80-8AEB-3B31E74C3F9A

P50

Q26798420-466B78D8-76D0-454B-B67A-C00A075546AD

Q26798420-765E0121-31BF-4D2F-BD5E-A92A79953519

Q26798420-8B03E2E7-19E8-4753-9AF5-6A34C9FF7171

Q26798420-A2C4C7F6-6D15-4C4F-BDBB-DBCFFA8B9C4E

Q26798420-C3245A66-4FAE-47C8-AB46-E75E25E073E5

Q26798420-E64614DA-14F7-4092-9F45-51057F8364EF

P5008

Q26798420-29F75C46-58FE-4916-9CA8-F9348DF3513C

P577

Q26798420-5BCE4331-89F8-40CB-AA9D-DD604745A3C6

P5875

Q26798420-562821AC-F3E8-4E88-AA7F-42F776FEB039

P698

Q26798420-5AC30825-408A-4C19-A55F-5567455031A2

P921

Q26798420-855D95A0-9DA0-489D-8556-D40D2C2CEA12

Q26798420-95814860-6D8E-46C2-8C58-6C7957BE481B

Q26798420-E300D287-29FC-4F3D-BC5F-9C418BF75E2F

P932

Q26798420-E8F974C2-B42C-44A8-BCC0-CE5ADFDF6D3D

P3181

P356

ONCOTARGET.4990

P1433

P1476

Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy

@en

P2093

Bruno Nervi

http://www.w3.org/2001/XMLSchema#string

Helga Weber

http://www.w3.org/2001/XMLSchema#string

Marcelo Garrido

http://www.w3.org/2001/XMLSchema#string

Patricia García

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Mutations of PIK3CA in gastric adenocarcinoma

Global cancer statistics

Chemotherapy for advanced gastric cancer

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases

New strategies for advanced neuroendocrine tumors in the era of targeted therapy

Role of Notch signaling pathway in gastric cancer: a meta-analysis of the literature

Regulation of ovarian cancer stem cells or tumor-initiating cells

Gastric cancer stem cells: a novel therapeutic target

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

P304

24750-24779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2666804

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.4990

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Ismael Riquelme

Juan Carlos Roa

Carolina Bizama

Jaime A Espinoza

Kathleen P Saavedra

P5008

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280998833

http://www.w3.org/2001/XMLSchema#string

P698

26267324

http://www.w3.org/2001/XMLSchema#string

P921

stomach neoplasm

mechanism of action

P932

4694793

http://www.w3.org/2001/XMLSchema#string